Phagenesis Ltd
1 follower
Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplastici... Read more
Org chart
Anil Keni
Vice President, Global Marketing
Cari Manypenny
Senior Manager, Global Clinical Education
Fred Edenius
Director
Klaus Annewanter
Senior Business Development Manager Europe
Rebecca Oxtoby
Senior Therapy Development Manager - UK And Ireland
Scott Grant
Vice President Therapy Development
Yasmin Wan (ACCA)
Group Finance Manager
Andre Nel
Chief Financial Officer
Lorena Danilescu
Sr. Manager, US Office And Administration
Similar companies
On Target Laboratories
1 follower
Triplebar
2 followers
Synthekine
3 followers
Sapience Therapeutics, Inc.
1 follower
Forge Biologics
2 followers
Kyverna Therapeutics
5 followers
Merck
201 followers
Generate Biomedicines
3 followers
Day One Biopharmaceuticals
1 follower
Bionaut Labs
1 follower
Ventyx Biosciences
1 follower
Discover companies